Analystreport

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) had its "reduce" rating re-affirmed by analysts at UBS Group AG.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview